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Background:There is still no high resolution three-dimensional structure available for the membrane-spanning domain of
anion exchanger 1 (AE1).
Results: A three-dimensional model of AE1 membrane-spanning domain has been generated in silico and experimentally
assessed.
Conclusion: Transmembrane segments forming AE1 transport site have been identified.
Significance: This is the first three-dimensional model of AE1 membrane-spanning domain based on a cation symporter.
The anion exchanger 1 (AE1), amember of bicarbonate trans-
porter family SLC4, mediates an electroneutral chloride/bicar-
bonate exchange in physiological conditions. However, some
point mutations in AE1 membrane-spanning domain convert
the electroneutral anion exchanger into a Na and K conduc-
tance or induce a cation leak in a still functional anion
exchanger. The molecular determinants that govern ion move-
ment through this transporter are still unknown. The present
study was intended to identify the ion translocation pathway
within AE1. In the absence of a resolutive three-dimensional
structure of AE1 membrane-spanning domain, in silicomodel-
ing combined with site-directed mutagenesis experiments was
done.A structuralmodel ofAE1membrane-spanning domain is
proposed, and this model is based on the structure of a uracil-
proton symporter. Thismodelwas used to design cysteine-scan-
ningmutagenesis on transmembrane (TM) segments 3 and 5. By
measuring AE1 anion exchange activity or cation leak, it is pro-
posed that there is a unique transport site comprising TM3–5
and TM8 that should function as an anion exchanger and a cat-
ion leak.
The anion exchanger 1 (AE1,2 SLC4A1, or band 3) is the
main membrane protein in vertebrate red cells. It fulfills differ-
ent tasks in these cells: a structural role by linking plasmamem-
brane to cytoskeleton, a respiratory role by improving CO2
transport capacity of red cells, and an antigenic function (Diego
blood group and senescence), and it is also involved in cytoki-
nesis and red cell volume regulation (1). At the molecular level,
this protein is divided into twomain structural domains: a cyto-
plasmic N-terminal domain (about 400 amino acids) and a
membrane-spanning domain (about 450 amino acids) with a
short C-terminal tail in the cytoplasm. These two entities seem
to function independently: the large cytoplasmic domain is
involved in interactions with enzymes, hemoglobin, and struc-
tural proteins, whereas the membrane-spanning domain is
responsible for the transport activity of the protein (2, 3). In
addition to red cells, AE1 is also expressed in kidney -interca-
lated cells and cardiac myocytes (4). In physiological condi-
tions, AE1 exchanges one chloride for one bicarbonate by an
electroneutral transport mechanism with the driving force for
ion movement provided by their electrochemical gradient. A
few years ago, some specific point mutations were character-
ized and proposed to convert the electroneutral anion ex-
changer into a cation-conductive pathway (5, 6). These muta-
tions are associated with human pathologies (hereditary
hemolytic anemia and distal renal tubular acidosis) (7–10). In
addition to naturally occurring mutations identified in patients
with hereditary stomatocytosis or distal renal tubular acidosis,
a sequence-function analysis of AE1 revealed other amino acids
crucial for transport properties of the protein (11). Unexpected
transport activity ofAE1 had already been suggested in the past:
Tanner and co-workers (12) had shown that human AE1 could
behave as a conductive pathway when two putativemembrane-
spanning helices in the membrane domain of the protein were
removed. These data supported the work of Motais and co-
workers (13–16) who showed that trout AE1 forms an anion
conductive pathway permeable to organic (taurine and choline)
and inorganic (Na andK) ions in response to decreased ionic
strength in red cells. Moreover, AE1 is also able to mediate a
proton-anion cotransport when protonated (17, 18).
□S This article contains supplemental Figs. 1–6 and Tables 1 and 2.
1 Towhomcorrespondence shouldbe addressed: Inst. deBiologie deValrose,
Bâtiment de Sciences Naturelles, 28 av. Valrose, 06108 Nice Cedex 2,
France. E-mail: helene.guizouarn@unice.fr.
2 The abbreviations used are: AE, anion exchanger; TM, transmembrane;
hAE1, human AE1; MBS, modified Barth’s saline; PCMBS, para-chloromer-
curibenzene sulfonate; MTSEA, 2-aminoethyl methanethiosulfonate
hydrobromide; MTSET, 2-(trimethylammonium)ethyl methanethiosulfon-
ate bromide; MTSES, 2-sulfonatoethyl methanethiosulfonate; DIDS, 4,4-
diisothiocyanostilbene-2,2-disulfonate; NI, non-injected; g d.w., g of dry
weight.
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Thus, transport features of AE1 seem to be flexible in
response to different stimuli such as mutations (point muta-
tions or deletions), intracellular ionic strength, and pH. The
identification of AE1 as a key actor in some types of hereditary
stomatocytosis associated with cation-leaky red cells reinforces
the interest in understanding the transport process through
AE1 protein. Although the three-dimensional structure of AE1
cytoplasmic domain has been solved, the three-dimensional
structure of the membrane-spanning domain is not yet avail-
able with a resolution high enough to determine the helical
packing of the entire membrane domain or to provide insights
into the transport mechanism at the molecular level. Thus, our
present understanding of ion transport is mainly based on bio-
chemical and functional studies. In an attempt to define the
AE1 transport site, cysteine-scanning mutagenesis has been
used, and it was shown that the eighth putative helix (TM8) in
AE1membrane-spanning domain lined the anion exchange site
(19). Moreover, it has been proposed that this putative TM8
was also involved in the cation leak induced by specific point
mutations in AE1 (11). These data point to a unique transport
site in the AE1 membrane domain. Its transport mechanism
and selectivity could then be modified by specific point
mutations.
To further understand the topology and the structure of the
AE1 transport site, we combined in silico proteinmodeling and
site-directed mutagenesis. A three-dimensional model of AE1
membrane-spanning domain was generated, and its reliability
was assessed by experimental and bibliographical data mining.
The present data show that putative TM3, TM5, and TM8
form a central core strongly involved in AE1 transport activity.
Cysteine-scanning mutagenesis in these helices allowed identi-
fication of residues lining the anion exchange pathway in WT
AE1.Moreover, working with a point-mutated AE1 (H734R) in
which the anion exchange was converted into a cation leak, it
was shown that the same domain was also involved in cation
transport. Some key amino acids in TM5 control anion
exchange activity of the protein: their substitution abolished
anion exchange activity and/or induced a Na and K leak.
This study proposes a spatial organization of the membrane-
spanning domain and identifies three helices involved in the
formation of the transport site. Moreover, this study confirms
that this transport site is able to function as an anion exchange
and/or a cation leak.
EXPERIMENTAL PROCEDURES
Three-dimensional Structure Prediction andModeling—The
structural modeling of the AE1 human sequence (UniProt
accession number P02730) was restricted to the C-terminal
sequence, starting from positions 399 to 911. This region
encompasses the transmembrane domain. A search for homol-
ogous sequences in the Protein Data Bank with BLAST or PSI-
BLAST did not retrieve any result except for the cytoplasmic
loop (positions 804–835; Protein Data Bank code 1BH7) and
the first and second transmembrane spans (positions 399–431
(Protein Data Bank 1BZK) and positions 437–457, respec-
tively) that were solved by NMR. Hence, we resorted to using
the I-TASSER method (web service version) that combines a
threading approach with fragment prediction. We looked for
structural templates with or without imposing constraints. We
also tested alternative tools separately such as the HHpred web
server, SAM-T08 web server, and DELTA-BLAST tool
(Domain Enhanced Lookup Time Accelerated BLAST)
recently implemented on the NCBI web site. In the case of
I-TASSER, the three first models showed very close C-scores
(2.24, 2.24, and 2.28, respectively) and similar cluster
densities. Among the top 10 templates with a significant over-
lap (70%) were the glucose symporter (Protein Data Bank
code 3DH4) and the uracil transporter (ProteinData Bank code
3QE7). The other prediction tools only retrieved the latter, i.e.
Protein Data Bank code 3QE7. Despite a rather low identity
score (20%), the E-value and p value provided by the HHpred
tool encouraged us to proceed with the corresponding tem-
plate. This template is mainly used in model 3 of I-TASSER.
We then performed a forward-backward approach that con-
sisted of the following: 1) selecting a model in which residues
were close enough to be consistent with experimental data
available (see “Results” and “Discussion”), 2) designing muta-
tions that could interfere with the putative channel, and 3)
refining the model if required. Refinement mainly consisted in
rotating TM5 helix around the helical axis to account for prox-
imities deduced from the impact of mutations established by in
vivo experiments. Local distortions in helical backbone gener-
ated by the rotation were removed by imposing helical second-
ary structure constraints inTM5andTM8 segmentswithMod-
eler software. The model was then relaxed with 1000 steps of
steepest descent minimization using the Amber force field
implemented in Chimera software (20). In the resulting three-
dimensional structure, 92% of the residues are located in favor-
able or acceptable regions of the Ramachandran diagram. Note
that we did not refine conformation of the loops as the presence
of the membrane would be required.
Functional Expression of AE1—The experimental proce-
dures are identical to those described in our previouswork (11).
Construction of hAE1 cDNA with Point Mutations—The fol-
lowingmutationswere constructed: S465C/I/A, L468C, F471C,
E472C, E473C, and F475C in putative TM3 and S525C, F526C,
I528C, S529C, L530C, F532C, I533C, Y534C, E535C, F537C,
K539C, L540C, I541C, and K542C in putative TM5. Site-di-
rected mutagenesis was performed on wild type human
erythroid AE1 cloned in pSP65 using the QuikChange site-di-
rected mutagenesis kit (Stratagene) with primers covering 15
bases upstream and downstream of the mutation (Eurogentec,
Seraing, Belgium). One positive clone for each mutation was
sequenced before further use (Beckman Cogenics, Takeley,
UK). The plasmid with H734R point mutation in AE1 was
described previously (11). It was used to introduce cysteine in
TM5orTM3, taking advantage of a unique restriction site (PsiI)
betweenTM3orTM5and theHis734 position. ThePsiI-HindIII
digestion of AE1 plasmids with cysteine in TM3 or TM5 was
purified and ligated with the PsiI-HindIII digestion of H734R
mutant. Recombinant plasmids carrying the double mutation
Cys in TM3 or TM5 and H734R were further sequenced to
check constructions.
Oocyte Injection—Isolation and cRNA injection of oocytes
were performed as described previously (13). Briefly, HindIII-
linearized pSP65hAE1WT and mutant plasmids were tran-
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scribed by SP6 RNA polymerase (Ambion transcription kit).
Female Xenopus laevis were anesthetized with MS222 accord-
ing to the procedure recommended by our ethics committee.
Stage V-VI oocytes were injected with 10 ng of AE1 (WT and
mutated) cRNA. Injected oocytes were maintained at 18 °C in
modified Barth’s saline (MBS) for 3 or 4 days before running the
experiments. MBS composition was as follows: 85 mM NaCl, 1
mM KCl, 2.4 mM NaHCO3, 0.82 mM MgSO4, 0.33 mM
Ca(NO3)2, 0.41 mM CaCl2, 10 mM HEPES, 4.5 mM NaOH, pH
7.4 supplemented with 10 units/ml penicillin and 10 g/ml
streptomycin. For Na and K contentmeasurements, oocytes
were incubated in MBS with 0.5 mM ouabain and 5 M bumet-
anide. Cl/HCO3 exchange activity, Na andK contents, Li
uptake, and biotin labeling of membrane proteins were deter-
mined on the same batch of oocytes 3 or 4 days after injection.
Thiol Alkylations—Thiol alkylation of cysteines was per-
formed by oocyte incubation for 15 min at room temperature
in MBS with 1 mM para-chloromercuribenzene sulfonate
(PCMBS; Sigma) or 5 mM 2-aminoethyl methanethiosulfonate
hydrobromide (MTSEA) extemporaneously prepared from
stock solutions (1 M in DMSO) stored at 20 °C. For 2-(tri-
methylammonium)ethyl methanethiosulfonate bromide (MTSET)
and 2-sulfonatoethyl methanethiosulfonate (MTSES), they
were weighted and solubilized in MBS at 5 mM just before use.
(MTS reagents were form Toronto Research Chemicals, Can-
ada). After 15 min, oocytes were washed in MBS and directly
assessed for Li uptake experiments or pHi measurements.
Oocyte Na and K Content Measurements—As published
previously (13), oocytes incubated in MBS with ouabain and
bumetanide were quickly washed two times in 7.5ml ofMilli-Q
water (Millipore) and dried on aluminum foil overnight at 80 °C
after removing excess extracellular fluid. Dried oocytes were
weighted to determine dry cell solids. Intracellular ions were
extracted by suspending dried oocytes in 4 ml of Milli-Q water
overnight at 4 °C. Measurements of sodium and potassium
were done with a flame spectrophotometer (Eppendorf). For
each experiment, a triplicate was made for each condition, and
results were expressed as micromoles/gram of dry cell solids.
Cl/HCO3Exchange ActivityMeasurements—Oocyte intra-
cellular pH was measured using selective microelectrodes as
published previously (5).
The ability ofWT andmutant hAE1 to regulate intracellular
pH was assessed by measuring the intracellular pH of oocytes
acidified by incubation in medium (63.4 mM NaCl, 1 mM KCl,
24 mM HCO3, 0.82 mM MgSO4, 0.33 mM Ca(NO3)2, 0.41 mM
CaCl2, 5 mM HEPES/NaOH, pH 7.35, 5% CO2, 95% O2) and
then bathed with MBS without Cl (63.4 mM sodium gluco-
nate, 1 mM potassium gluconate, 24 mM HCO3, 0.82 mM
MgSO4, 0.74 mM Ca(NO3)2, 5 mM HEPES/NaOH, pH 7.35, 5%
CO2, 95% O2). Results are given in pHi/min S.E. pHi was
measured when acidified oocytes were exposed to Cl-free
medium; it corresponds to the initial slope of the alkalinization.
LiUptake—Liwas used as a substitute forNa tomeasure
oocyte cation permeability. To prevent cation movements
through the Na,K-ATPase or the Na-K-2Cl cotransporter,
Li uptake was done in presence of 5 M bumetanide and 0.5
mMouabain in LiNO3MBS (85mMLiNO3, 1mMKNO3, 2.4mM
NaHCO3, 0.82mMMgSO4, 0.33mMCa(NO3)2, 0.41mMCaCl2,
10 mM HEPES, 4.5 mM NaOH, pH 7.4). In each experiment,
nine oocytes per condition were incubated for 2 h in LiNO3
MBS at 19 °C. Li was quantified in each individual oocyte by
atomic absorption spectrometry with a PerkinElmer Life Sci-
ences AAS3110 instrument. Results are expressed in pmol/
oocyteh (mean  S.E. of nine oocytes per experimental
condition).
AE1 Immunodetection on Oocyte Plasma Membrane—To
detect AE1 addressed to the oocyte plasma membrane, surface
proteins of oocytes expressing WT or mutated AE1 were
labeled with sulfo-NHS-SS-biotin (sulfosuccinimidyl-2-[bioti-
namido]ethyl-1,3-dithiopropionate; Pierce) in MBS, pH 8 at
4 °C as described previously (11). After a 15-min incubation, the
reaction was quenched with buffer (192 mM glycine, 25 mM
Tris-HCl, pH 7.5, 0.1 mM CaCl2, 1 mM MgSO4), and oocytes
were washed in MBS, pH 8. Oocytes were then lysed mechani-
cally in homogenization buffer (20 mM Tris-HCl, pH 7.4, 250
mM sucrose, 0.5 mM EDTA, 0.5 mM protease inhibitor Pefabloc
(Roche Applied Science)), and oocyte membranes were solubi-
lized in radioimmune precipitation assay buffer (150 mMNaCl,
1 mM EDTA, 50 mM Tris-HCl, pH 8, 1% Nonidet P-40, 0.5%
deoxycholate, 0.1% SDS, 0.5 mM Pefabloc) for 30 min at 4 °C.
Biotin-labeled proteins in the solubilized membranes were iso-
lated by immobilization on avidin resin (Pierce) for 30 min at
4 °C. After washing in radioimmune precipitation assay buffer,
biotin-labeled proteins were eluted in SDS-PAGE loading
buffer, analyzed by SDS-PAGE, transferred to PVDF mem-
brane (Millipore), and probed with primary antibodies as indi-
cated in the figure legends. Secondary antibodies were anti-
rabbit or anti-mouse horseradish peroxidase-coupled (Sigma)
and detected by chemiluminescence reaction with Immobilon
Western reagent (Millipore) and a Fusion FX7 imaging system
(Vilber-Lourmat, France). To compareAE1 expression levels in
different samples, the cell membrane marker 1 Na,K-ATPase
was used. The intensity of each AE1 band relative to the total
membrane fraction (1 Na,K-ATPase signal) was quantified in
each lane with NIH ImageJ software.
RESULTS
Model of AE1Membrane-spanning Domain
Structural modeling of AE1 is problematic because of the
absence of homologous structure available. Even the location of
transmembrane segments is subject to controversy; the number
and limits of transmembrane (TM) segments are dependent on
the prediction tools used (see supplemental Table 1). The con-
sensus is better in theN-terminal transmembrane domain from
residue 398 to residue 728. In most cases, this domain encom-
passes eight transmembrane helices, but their length and pre-
cise location vary depending on the tool. The region from res-
idue 730 to the end is much more variable with the number of
helices ranging from 1 to 5. Similarly, prediction of inside/out-
side topology is also rather fuzzy. Altogether, these tools do not
provide three-dimensional information (i.e. three-dimensional
proximities of transmembrane segments) but help in consider-
ing alternative topologies. For predicting three-dimensional
structures in the absence of clear homology, alternative
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approaches are required. Therefore, we resorted to the
I-TASSER method.
Among the five models proposed by I-TASSER, three of
them were rather similar up to residue 850. These models are
mostly based on the uracil transporter (Protein Data Bank code
3QE7). Model 2, based on the importin  subunit, was dis-
carded because its topology was not compatible with most data
available. Model 1 presented a topology based on the Na-glu-
cose symporter and at first glance seemed of interest. Surpris-
ingly, any tools we tested never retrieved the structural tem-
plate suggested by Yamaguchi et al. (21), the bacterial chloride
channel (Protein Data Bank code 1OTS). When the corre-
sponding template (Escherichia coli chloride-proton exchanger
(ClCA)) was imposed in I-TASSER, the resulting models did
not respect the imposed topology, showing that the sequence-
structure compatibility was not large enough to be imposed.
Hence, we mainly ended up with two different topologies.
Model 1 is based on theNa-glucose symporter, andmodel 2 is
based on the uracil transporter. Note that both are cation sym-
porters. A careful inspection of model 1 showed that (i) the
C-terminal end was extracellular and thus not compatible with
experimental data and (ii) the location of Lys851 and Lys539
(intra- and extracellular, respectively) prevented their cross-
linking by 4,4-diisothiocyanostilbene-2,2-disulfonate (DIDS)
in disagreement with experimental data.Moreover, using alter-
native tools, we systematically retrieved the second template,
i.e. Protein Data Bank code 3QE7. Supplemental Fig. 1 illus-
trates the structural alignment between AE1 transmembrane
domain and uracil transporter (Protein Data Bank code 3QE7).
In addition, the E-value and p value, which estimate the rele-
vance of the alignment, led us to consider the proposed tem-
plate. Hence, we focused on thismodel to identify helices form-
ing the transport site.
We used the PPM server (22) to determine the limits of the
transmembrane segments in the model (see supplemental
Table 2). The topology of the model presents 12 transmem-
brane helical segments with two additional segments having a
mixed structure, -helix/coil. For convenience, the segments
are numbered according to their predicted location in the
membrane regardless of their secondary structure (Fig. 1).
There is a symmetry between TM4–5 and TM11–12, which
form two inverted arches more or less of the same width. The
helical parts of TM3 (in between TM4 and TM5) and TM10 (in
between TM11 and TM12) point toward each other. TM1,
TM2, and TM9 are located within the space delimited by
TM4–5 and TM11–12. TM8 forms a long tilted helix span-
ning through this space parallel to the orientation of TM3 
TM10. TM6–7 and TM13–14 are arranged at the periphery of
the structure. TM1–7 andTM8–14 structures are symmetrical
(supplemental Fig. 2).
Note that the present model should be considered as a com-
plementary tool to test new hypotheses and to guide experi-
ments but should not be used to conduct intensive atomistic
simulations. Nowadays, the tools, like QMEAN server, one of
the most efficient tool available for assessing the accuracy of a
structural model, are not appropriate to validate a transmem-
brane protein model (23). ProQM, the only tool available to
assess membrane protein models, indicated that the quality of
the model is medium (24). However, the present model pro-
vides useful information regarding helix spatial organization
that should be further validated experimentally. The results
detailed in the next sections strongly support the relevance of
the model despite its low resolution.
Mutagenesis in TM5 and TM3
It has been shown that TM8 lines the anion exchange path-
way of AE1. In the selectedmodel, TM8 appears as a long tilted
helix. Viewed from the top, the pathway along TM8 that was
shown to drive anions partially faces TM5.Moreover, TM3 is in
between the top of TM8 and TM5 (Fig. 1B). Thus, the possibil-
ity for TM8, TM5, and TM3 to be involved in the formation of
AE1 transport site was investigated.
Putative TM5 contains a highly conserved amino acid
sequence among anion exchangers SLC4A1, -A2, and -A3
(F532IYE535), and especially Ile533 is present in all known SLC4
anion exchangers (supplemental Fig. 3). Moreover, the anion
exchanger inhibitor DIDS covalently binds to Lys539 at the top
of this putative TM5. However, this lysine is not directly
involved in the transport site (25). It is possible to cross-link
Lys539 with Lys850 by DIDS, and this induces a covalent inhibi-
tion of anion exchange. The selected model places Lys539 and
Lys850 in a position compatible with their cross-linking.
In putative TM3, sequence G463FSGPL468 is conserved in
vertebrate SLC4A1, -A2, and -A3, and it has been proposed to
correspond to one of the chloride binding sites of ClC (consen-
sus sequence GSGIP) (26). To determine the role of TM5 and
TM3 in AE1 transport activity, a cysteine-scanning mutagene-
sis combined with sulfhydryl-specific chemical labeling was
done.
In TM5, residues Ser525, Phe526, Ile528, Ser529, Leu530, Phe532,
Ile533, Tyr534, Glu535, Phe537, Lys539, Leu540, Ile541, and Lys542
were changed one by one for cysteine. A similar approach was
used to study the involvement of TM3 residues Ser465, Leu468,
Phe471, Glu472, Glu473, and Phe475. Ser465 was substituted with
cysteine, isoleucine, or alanine. This amino acid was proposed
to correspond to Ser107 in Cl channels, which are involved in
anion translocation. Leu468, Phe471, Glu472, Glu473, and Phe475
were substituted with cysteine. All mutants were expressed in
Xenopus oocytes, and their correct addressing to oocyte plasma
membrane was assessed by immunodetection of biotinylated
AE1 on Western blots (supplemental Fig. 4).
The variation of AE1 expression level at the plasma mem-
brane is fairly high as visualized by the large S.E. This discrep-
ancy could be linked to differences between batches of oocytes,
but it is also due to the calculationmethod. These bars show the
ratio of chemiluminescence associatedwith overexpressedAE1
over that associated with the endogenous 1 subunit of the
Na,K-ATPase. The large difference between these two signals
emphasizes variations between experiments. Thus, it was not
possible to establish statistically significant differences between
mutants and WT AE1 with regard to their expression level
except for S525C mutant in TM5 and S465A, E472C, and
F475C in TM3 that were significantly less expressed than the
WT AE1 in all experiments.
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Transport Properties of theMutants
Mutations in TM5—The anion exchange activity of cysteine
mutants in TM5 was assessed. As shown by Fig. 2, all mutants
were functional, i.e. able to exchangeCl andHCO3, except for
I528C, F532C, andE535C. In these threemutants, loss or strong
reduction of anion exchange ability is not due to a reduced
expression of the protein in oocyte plasma membrane (supple-
mental Fig. 4B). Only the S525C mutant exhibited a decreased
Structural Model of SLC4A1 and Transport Site Identification
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anion exchange activity that is correlated to a decreased expres-
sion level of the protein. Thus, S525Cmutation does not impair
AE1 transport features but rather decreases the amount of pro-
tein at the plasma membrane. As previous experiments have
shown that some AE1 point mutations induced a Na and K
leak, the cation permeability of oocytes expressing WT and
mutated AE1 was also assessed.
Oocyte Na and K contents were measured after 3 days of
AE1 expression (Fig. 3A). To be able to compare data from
different batches of oocytes with varying basal Na and K
contents in control oocytes (non-injected (NI)), results were
expressed as the difference in Na and K contents between
oocytes expressing WT or mutated AE1 and non-injected
oocytes. We observed that mutations F526C, I528C, F532C,
Y534C, K539C, and L540C induced a significant increase in
Na content correlated to a significant decrease in K content.
Considering S.E. values, only changes over 20% of cation con-
tents were considered as significant. Thus, variations between
NI and AE1-expressing oocytes below 10 mol/g of dry weight
are not significant. To confirm the faint cation leak for Y534C
and K539Cmutants, oocytes were incubated for 5 days inMBS
with ouabain and bumetanide. In this case, Na  26.6 
8.6mol/g d.w. andK21.1 4.5mol/g d.w. for Y534C
andNa22.8 6.3mol/g d.w. andK27.6 5.7
mol/g d.w. for K539C. By contrast, E535Cmutant did not leak
Na or K after 5 days in MBS with ouabain and bumetanide.
The cation permeability was also assessed by Li influx
measurements (Fig. 3B). All the mutants able to change oocyte
Na andK contents exhibited a significant Li influx. The Li
influxmeasured in oocytes expressing E535Cwas slightly above
control levels. However, this low increase in cation permeabil-
ity was not associated with changes in Na and K content in
contrast to L540C for which a low Li influx was also detected.
We did not further investigate the significance of the low Li
influx of E535C-expressing oocytes.
To assess whether TM5 lines the transport site, the anion
exchange activity and the cation transport activity (when
observed) were measured after binding of the following thiol
reagents with different sizes and charges: MTSEA (cationic/
neutral, 10:1 at pH 7.5), MTSET (cationic), MTSES (anionic),
and PCMBS (anionic). We observed that PCMBS blocked
anion exchange through L530C and I533Cmutants (Fig. 4A) by
80 and 70%, respectively. Neither MTSEA nor MTSES at 5 mM
inhibited anion exchange in oocytes expressingWT or cysteine
mutants. For clarity, these data were not plotted in the figure.
For the four mutants inducing a cation leak (F528C, F532C,
Y534C, and K539C), Li influx was insensitive to PCMBS,
MTSET, and MTSEA.
FIGURE 1. Human AE1 topology (A), three-dimensional model (B), and spatial organization of the transport domain (C and D). A, topology of AE1
membrane-spanning domain deduced from the three-dimensional model. The gray rectangles represent -helices spanning the membrane bilayer. Circles
highlight residues that are along the ion pathway through the protein. Some amino acids that have been shown to be important for AE1 transport features are
inbold: Glu681 in TM8;Asp705 in TM9; andArg730, Ser731, andHis734 in TM10 frompreviouspublications andSer465 in TM3andPhe526, Ile528, Phe532, Tyr534, Glu535,
Lys539, and Leu540 in TM5 from the present experiments. B, dotted lines indicate putative lipid bilayer width. The short size of TM13 and TM14 is similar to what
is observed in uracil transporter UraA where they are halfway into the membrane. In the connecting loop between TM13 and TM14 lies the Lys851 that
cross-reacts with Lys539 in the top part of TM3 through covalent binding to DIDS (the distance between the two lysines is compatible with the size of DIDS
molecule, i.e. 20 Å). C, enlargement of the center for ion transport. Amino acids that have been experimentally shown to be involved in ion transport are
highlighted: Leu468, Phe471, and Ser465 in TM3; Glu681 in TM8; Leu530 and Ile533 in TM5; andArg730 andHis734 in TM10. For clarity, only TM12-5-3-10 and TM8 are
shown in this side view. In TM8, amino acids lining the ion transport site are also shown.D, extrapolation to AE1 of the functional organization of UraA. A core
domain (gray) and a gate domain (blue) that associate with each other through hydrophobic interactions are shown. Figures were preparedwith PyMOL.Nter,
N terminus.
FIGURE 2.Anion exchange ofWTAE1 and cysteinemutants in TM5. A, representative intracellular pHi recordings in oocytes expressingWT AE1 and F532C
and K539C mutants. Each trace comes from different experiments performed with different pHi sensitive-electrodes. wtAE1, wild-type erythroid AE1. B, the
ability of oocytes to recover from an acid load in CO2/HCO3
-buffered MBS was expressed as pHi/min. This corresponds to the initial slope of the curve
recorded in medium without Cl. Data are means S.E. (error bars) of n (number in bars) oocytes from different batches (Student’s t test; *, p 0.05).
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Mutations in TM3—Fig. 4B illustrates the anion exchange
activity of mutants in TM3. S465C, S465A, L468C, F471C, and
F475Cwere still able to exchange Cl and bicarbonate. By con-
trast, S465I and E472C abolished anion exchange activity,
whereas E473C drastically reduced anion exchange activity.
E472C was hardly detectable at the plasma membrane; thus, it
is not possible to make conclusions about the effect of this
mutation on anion exchange activity per se (supplemental Fig.
3C). S465I and E473C on the other hand were expressed at the
plasma membrane, and the lack of anion exchange activity of
thesemutants points to a role for Ser465 andGlu473 in the trans-
port process. The effect of PCMBS binding to cysteine mutants
in TM3 was then assessed. This reagent strongly decreased
anion exchange of L468C and F471Cmutants (Fig. 4B). None of
the substitutions on TM3 residues induced a cation leak (eval-
uated by cation content after 3 days in MBS with ouabain and
bumetanide).
Involvement of TM5 and TM3 in Cation-leaky AE1—In pre-
vious studies, it was shown that H734Rmutation converted the
anion exchanger into a cation conductance (5). The H734R
mutation is associated with a hereditary stomatocytosis (9).
The question arises as to whether the cation leak induced by
H734Rmutation was sensitive to cysteinemutations in TM5 or
TM3 and whether this cation leak could be blocked by sulfhy-
dryl reagents binding cysteine in TM5 or TM3.
The following doublemutants, H734R and cysteine substitu-
tions in TM5 that did not induce a cation leak per se, were
constructed: S525C/H734R, S529C/H734R, L530C/H734R,
I533C/H734R, E535C/H734R, F537C/H734R, L540C/H734R,
I541C/H734R, and K542C/H734R. Moreover, another double
mutant, F526C/H734R, a Cys mutant able to induce a cation
leak, was also constructed. The Li influx induced by H734R
mutations alone is greater than the Li influx induced by single
cysteine mutations in TM5 (Fig. 5A compared with Fig. 3B).
Moreover, we observed that an additional cysteine substitution
in H734R mutant at the following positions increased the Li
influx: F526C, S529C, F537C, L540C, and I541C. The greater
Li permeability of F526C/H734R, S529C/H734R, F537C/
H734R, L540C/H734R, and I541C/H734R double mutants is
not explained by a higher amount of protein at the plasma
membrane (supplemental Fig. 5).
The effect of chemical reagent binding on accessible cysteine
was then assessed on these double AE1 mutants. Oocytes
expressing AE1 H734R/Cys double mutants in TM5 were
treated with MTSET, MTSEA, or PCMBS prior to Li influx
measurement. Fig. 5B shows that two positions, Cys530 and
Cys533, were affected by MTSET and/or PCMBS treatment in
H734R mutant. MTSET inhibited by 25% Li influx of oocytes
expressing L530C/H734R mutant, whereas PCMBS and
MTSET inhibited by 45 and 33%, respectively, Li influx of
oocytes expressing I533C/H734R. As MTSEA (5 mM) did not
significantly change Li influx of any double mutants, these
results were not plotted in Fig. 5 to avoid confusion.
Thus, positions Cys533 and Cys530 are both accessible in the
anion exchange conformation of WT AE1 and in the cation
leaky conformation of H734R mutant. Moreover, they are
involved in the anion exchange activity as well as in the cation
leak.
As it was observed that PCMBS blocked anion exchange of
two cysteine mutants in TM3 (L468C and F471C), the involve-
ment of these two positions in the cation leak induced by
H734Rmutation was also assessed. Moreover, the involvement
of Ser465 was also checked on cation leak induced by H734R
mutation. Double mutants L468C/H734R, F471C/H734R, and
S465I/H734R were constructed, and their expression level at
the plasma membrane was not significantly different from that
ofWTAE1 (supplemental Fig. 5). Fig. 6 illustrates the Li influx
of L468C/H734R, F471C/H734R, and S465I/H734R constructs.
This influx was not inhibited by 1 mM PCMBS or 10 mM
MTSET treatment. Remarkably, a strong reduction of Li
influx was observed in oocytes expressing S465I/H734R
mutants, suggesting the importance of Ser465 in the cation leak
induced by H734R mutation.
DISCUSSION
The goals of the present experiments were to identify the ion
transport site within AE1 membrane-spanning domain and to
propose a spatial organization of this domain. TheAE1model is
FIGURE 3. Cation permeability of oocytes expressing WT AE1 and cys-
teinemutants in TM5.A, intracellular Na and Kweremeasured in oocytes
3 days after injection and incubation in MBS with ouabain and bumetanide.
The variation in Na and K contents between control, NI oocytes, and AE1-
injected oocytes was calculated for each experiment. The absolute value of
these variations was averaged, and data aremeans S.E. (error bars) of three
to six different experiments depending onmutants. The mean value for Na
content in NI oocytes is 50.1 4.5 mol/g d.w. (n 14). The mean value for
K content in NI oocytes is 59.2 5.5mol/g d.w. (n 14).wtAE1, wild-type
erythroid AE1. B, Li influx ratio in oocytes expressing WT AE1 and cysteine
mutants. To be able to compare experiments with varying basal Li influx in
NI oocytes (from a minimum of 42 to a maximum of 250 pmol/hoocyte
depending on oocyte batches; mean, 139 20 pmol/hoocyte; n 15 inde-
pendent experiments), Li influxes in oocytes expressingWT ormutated AE1
were normalized to the basal Li influx in each experiment. Data are
expressed as percentage of NI as means S.E. (error bars) of three (WT AE1,
S525C, F526C, S529C, L530C, I533C, F537C, L540C, I541C, and K542C), five
(F532C andK539C), or seven (I528C, Y534C, and E535C) different experiments
(Student’s t test; *, p 0.05).
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based on the structure of UraA, the uracil-H cotransporter
(27). At first glance, this result is unexpected for an electroneu-
tral anion exchanger, which is more likely compared with chlo-
ride channel familymembers. Indeed, a recent interpretation of
electron density maps of AE1 crystals proposed some similari-
ties with Cl channel structure (21). Some long and tilted
helices could be identified in AE1 crystals, and two V-shaped
densities inserted into the membrane from opposite sides were
also identified. These V-shaped helices are found in Cl chan-
nel structure (28). However, V-shaped helices are also found in
H or Na symporters. In addition, amino acid sequence sim-
ilarity between AE1 membrane-spanning domain and UraA or
ClCA does not favor the chloride channel, these sequences are
quite similar. Nevertheless, although all the tools we used failed
to identify ClCA as an appropriate template, we built homology
models using two different alignments. Whatever the align-
ments, the results did not match available functional and topo-
logical data. For instance, residues Leu530, Ile533, Leu669, Leu673,
Leu468, and Phe471 shown to influence transport properties
were far away in the models based on ClCA. The region from
Arg808 to Leu835 that was shown to be intracellular on the basis
of antibody recognition (42) is exposed to the extracellular
medium in the model based on ClCA. All these results tend to
confirm that that UraA template would be more appropriate.
It should be noted that UraA structure is also a double funnel
shape structure related by an internal 2-fold symmetry. This
kind of structure, observed in Na symporters for example,
allows transport of many different solutes: amino acids, sugar,
nucleobase, glycerol, and water with H, Na, K, and/or Cl
ions (28–31). Asmentioned previously, AE1 is able to transport
amino acids, urea, Na, and K and form an anion conductive
pathway in trout erythrocytes (5, 12, 13, 15, 16). Point muta-
tions convert the electroneutral humanAE1 into aNa and K
conductance (5). To some extent, AE1 shows transport similar-
ities with the glutamate transporter, an anion channel with glu-
tamate, Na, and K permeability, that has a structure related
to Na-coupled transporters (29).
The three-dimensional AE1 model presents 14 transmem-
brane segments arranged into two structural repeats, TM1–7
and TM8–14 (supplemental Fig. 2). TheN-terminal and C-ter-
minal parts are cytoplasmic. As for UraA, two transmembrane
segments are partly helical, TM3 and TM10, and these two
half-helices are superimposed. In UraA, these semihelical
membrane -spanning segments are crucial for uracil binding
and present a short -strand that is not observed in the AE1
model. Similar discontinuous helices symmetrically related are
also observed in neurotransmitter-, amino acid-, and sugar-
sodium symporters and account for substrate binding (32). As
shown in Fig. 1B, Top view, AE1 membrane-spanning domain
can be divided into two parts: the transmembrane segments
1-2-3-4-8-9-10 and 11 on one hand and the transmembrane
segments 5-6-7-12-13 and 14 on the other hand. The relevance
of the proposed three-dimensional structure for AE1 can be
assessed by comparison with the available data accumulated
over more than 50 years to describe AE1 topology and
functioning.
FIGURE 4. Effect of PCMBSon anion exchange activity ofWT andmutatedAE1.White bars represent control condition.Gray bars represent pHi recovery of
oocytes treated for 15minwith 1mMPCMBSprior to intracellular pH recording. Data aremeans S.E. (error bars) of 10 oocytes fromdifferent experiments. The
control (ctrl) condition and sulfhydryl reagent condition were recorded on oocytes from the same batch of injection (Student’s t test between control and
PCMBS condition; *, p  0.05). A, cysteine substitutions in TM5. B, amino acid substitutions in TM3. The different level of WT AE1 anion exchange activity
between A and B could reflect the different periods of time at which the experiments on TM3 and TM5mutants were done. ThemeanpHi/min for WT AE1 is
0.063 with a standard error of 0.030 (n 41 recordings over 2 years).
Structural Model of SLC4A1 and Transport Site Identification
SEPTEMBER 13, 2013•VOLUME 288•NUMBER 37 JOURNAL OF BIOLOGICAL CHEMISTRY 26379
 by guest on June 20, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
A great number of experiments have been carried out to
determine AE1 topology. These data have led to two different
propositions: one with 13 -helices and a loop connecting the
extracellular C-terminal part of -helix 11 and the intracellular
N-terminal part of -helix 12 and one with 14 -helices (33–
37). These two topologies differ mainly after TM9 (Gly714) with
either five -helices spanning the lipid bilayer or four -helices
with a re-entrant loop between -helix 11 and 12 (residues
808–835). In our model, TM10 (residues Pro722 to Gln752)
corresponds to a transmembrane segment. Experimental evi-
dence has long questioned the sidedness of this region. The
amino acids in this region have been proposed to form an
extracellular loop on the basis of N-glycosylation-scanning
mutagenesis in a cell-free system or in transfected cells. Cys-
teine-scanning mutagenesis also favored this orientation
(37). However, in this domain, Lys743 was shown to be acces-
sible from the extracellular side or intracellular side depend-
ing on the kind of experiments (38, 39). Kanki et al. (40)
have proposed an explanation to these contradictory obser-
vations, and they concluded that during synthesis this
region is accessible from the extracellular side, and it is
later occluded within the AE1 molecule. This sequestration
requires TM1–3 and TM11. In the present model, this
domain forms a transmembrane span (TM10) that is in
accordance with the experiments of Kuma et al. (41) showing
FIGURE 5. Li influx in oocytes expressing cation-leakyAE1. A, Li influx in oocytes expressing H734Rmutant andH734R/Cys doublemutants in TM5. Data
are means S.E. (error bars) of three to five different experiments. B, effect of sulfhydryl reagents on Li influx induced by expression of H734R/Cys double
mutants in TM5. For each experiment, the Li influx for control condition was set at 100 pmol/hoocyte, and Li influx in MTSET- (0.5 mM) or PCMBS (1
mM)-treated oocytes was normalized to this value. Data are means S.E. (error bars) of three different experiments (Student’s t test; *, p 0.05).
FIGURE6.Li influxinoocytesexpressingdoublemutants(H734Randpoint
mutations in TM3).Data are means S.E. (error bars) of three different experi-
ments (Student’s t test; *, p 0.05). Only oocytes expressing L468C/H734R and
F471C/H734Rwere treatedwith PCMBS (1mM) orMTSET (5mM). Ctrl, control.
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that Lys743 is cleaved by intracellular proteases but not by
extracellular proteases in red cells.
The next two TMs, TM11 and TM12, are therefore oriented
in the opposite direction comparedwith the topology proposed
by Zhu et al. (33), and the long loop between TM12 and TM13
(Arg808 and Leu835) is intracellular. Wainwright et al. (42) have
shown that this loop corresponds to an intracellular loop on the
basis of antibody recognition (BRIC 132).
The controversy regarding the topology of the two regions
corresponding roughly to residues 720–760 and 808–835 has
recently been summarized by Hirai et al. (43). They proposed
two different topologies of AE1 (a and b) combining published
data and their analysis of the electron density maps of AE1
crystals. Our present model favors the topology called b with
region 720–760 forming a transmembrane segment and region
808–834 being an intracellular loop connecting TM12 and
TM13.Moreover, thismodel fits nicely with theworkingmodel
proposed by Groves and Tanner (35). By co-expressing pairs of
complementary fragments of AE1 combined with co-immuno-
precipitation in non-denaturizing detergent solutions, they
suggested that the core of the protein might comprise two sub-
domains containing the closely interacting TM spans 1–5 and
TM spans 9–12. The region containing TM spans 6–7 and
13–14 were proposed to be at the periphery of the core struc-
ture. In addition, it has been shown that deletion of TM6 and
TM7 from full-length AE1 does not prevent anion exchange
activity (12). However, this deletion changes AE1 transport fea-
tures because the protein develops an anion conductance in
place of an anion exchange. Thus, these two TMs are not
required for anion exchange but impose the electroneutral
transport behavior of anion exchange. Two AE1 point muta-
tions, R589H and S613F, associated with distal renal tubular
acidosis are located in TM6 and TM7, and they induce a cation
leak in a still functional anion exchanger (7). TM6 and TM7 are
not part of the ion path but probably participate in connecting
TMs involved in this function.
It is possible to reconstitute a functional anion exchanger by
co-expressing two independent cDNAs, one coding for the
N-terminal part of the protein until the end of putative TM5
and one coding for theC-terminal part of the protein starting in
putative TM6 (35). This suggests that the first five membrane-
spanning helices adopt a three-dimensional functional struc-
ture independently of the next TM segments. Moreover, it has
been shown that cutting this structure after putative TM4 did
not allow recovery of a functional anion exchanger. Thus, the
control of TM5 position by its link to TM4 appears to be essen-
tial for anion exchange activity.
The model shows that TM3 and TM5 share contacts with
TM8, which has been proposed to line the anion exchange
pathway. Thus, it was hypothesized that TM3 and TM5 could
be involved in the AE1 transport site, and cysteine-scanning
mutagenesis was done on conserved positions of these seg-
ments. The results of amino acid substitutions in TM3 and
TM5 are summarized in Table 1.
Among known sequences of anion exchangers (SLC4A1,
-A2, and -A3), there is a conserved consensus sequence in
TM3: G463F(S/T)GP(L/V)(L/M)(L/V)F(E/D)E473A(F/Y/L)(F/
Y/N/M)XF(C/S)479. In themodel, the helical part of TM3 starts
at Val470. Substitutions S465I and E473C abolished the anion
exchange activity, whereas thiol reagent binding on L468C and
F471C mutants prevented anion exchange, thus showing the
involvement of TM3 in transport activity of AE1. In addition,
TABLE 1
Summary of experimental data
For plasmamembrane immunodetection, refers to the immunodetection level ofWTAE1, and indicates that the protein was immunodetected at a lower level than
WT. All constructs were immunodetected. For anion exchange activity, there were five levels of signal ranging from to (no signal at all). refers to anion
exchange activity of WT AE1,  indicates very faint signal (0.01 pHi/min),  indicates anion exchange activity around 0.02 pHi/min, and  indicates that anion
exchange activity was reduced by about half compared withWT. For Na and K leak, indicates the presence of cation leak, and indicates the absence of cation leak.
AE1 amino acid
substitutions
Plasma membrane
immunodetection
Anion exchange
activity
Na and
K leak
Transport sensitivity to thiol
alkylation
WT AE1    None
TM3
S465C    None
S465I    None
S465A    None
L468C    PCMBS
F471C    PCMBS
E472C    None
E473C    None
F475C    None
TM5
S525C    None
F526C    None
I528C    None
S529C    None
L530C    MTSET (cation transport), PCMBS
(anion transport)
F532C    None
I533C    PCMBS (anion and cation transport),
MTSET (cation transport)
Y534C    None
E535C    None
F537C    None
K539C    None
L540C    None
I541C    None
K542C    None
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somemutations are probably responsible for AE1misfolding as
shown by reduced immunodetection at the plasma membrane
of S465A, E472C, and F475Cmutants. In zebra fish, the retsina
mutation corresponding to E472G substitution leads to the
absence of anion exchanger in erythrocyte membrane (44).
Altogether, these results indicate the importance of Glu472 in
TM3 for proper folding of AE1 and probably of all anion
exchangers because this Glu is highly conserved (it could be an
Asp in invertebrates). Moreover, Ser465 also appears to be
important for AE1 folding because its substitution by Ala led to
a lower detection of the protein at the plasmamembrane. How-
ever, this proteinwas still able to exchange anions. Thus, a polar
residue does not seem important in position 465 for anion
exchange activity. The size of the lateral chain is probablymore
important because S465I mutation prevented the anion
exchange activity of AE1without impairing protein expression.
Further studies simulating the effects of amino acid substitu-
tions on the model would help to better understand how Ser465
is involved in the transport mechanism and folding of the pro-
tein. Another amino acid substitution in TM3 of human AE1,
C479W, was shown to impair AE1 trafficking to the plasma
membrane as well as anion exchange activity (45).
Thus, our present results confirm the role of TM3 in AE1
folding and show in addition its involvement in anion exchange
activity. Especially residues Ser465, Leu468, Phe471, and Glu473
appear to play a role in anion translocation. Further experi-
ments should be done to better understand how these amino
acids are involved in the transport process.
Cysteine-scanning mutagenesis in TM5 showed that mu-
tants L530C and I533C react with thiol reagents, which prevent
anion exchange. This suggests that these residues are involved
in anion access to the AE1 transport site. Unlike Ile533, which is
conserved in the family of anion exchangers, Leu530 can be sub-
stituted with other non-polar residues (Ala in skate AE3 and
Val or Phe in invertebrate AE).
It is not possible to block anion exchange with thiol reagent
binding to positions below Leu530 and above Ile533 along a line
facing the space betweenTM5–3 andTM8.This could be inter-
preted either as limited access of the reagent to these positions
or as an absence of blocking of the anion exchangewhen bound.
This interpretation suggests that access to the transport site is
too large above Ile533 to be blocked by PCMBS, which is 9 Å
long with the thiol function (6.5 Å alone). Thus, the transport
site should narrow below Ile533. The model shows that the dis-
tance between TM5 and TM8 narrows between the facing res-
idues Ile533 in TM5 and Leu673 in TM8 (6.5 Å), which is com-
patible with the blocking effect of PCMBS binding to Cys533 as
well as to Cys673 in TM8 (19). Another interpretation of
PCMBS blocking could be that its binding to TM5 prevents
helix movements involved in transport process.
We observed that some substitutions of amino acids in TM5
are associated with changes in AE1 transport features. E535C
dramatically reduced anion exchange activity. I528C and
F532C mutations abolished the anion exchange activity and
induced a cation leak. F526C, Y534C, K539C, and L540Cmuta-
tions did not prevent anion exchange but induced a cation leak.
The Na and K gradients were dispelled by a ouabain- and
bumetanide-insensitive pathway. Thus, some positions in TM5
are crucial forAE1 transport features. It was already known that
either AE1 could be converted into a cation conductance or
that a cation conductance could be observed in a still functional
anion exchanger. These peculiar transport features result from
specific point mutations in the transmembrane domain (such
as H734R in TM10), and some of these point mutations are
associated with hereditary red cell or renal diseases (5, 7–10,
46). Our present results extend to TM5 the list of amino acids
that, when substituted in AE1, induce a Na and K leak in
Xenopus oocytes. With F526C, Y534C, K539C, and L540C
mutations, AE1 carries anion exchange and cation leak activi-
ties. With I528C and F532C mutations, there is no more anion
exchange activity; the exchanger is converted into a cation leak.
The intensity of the cation leak induced by cysteine substitu-
tions in TM5 is weak compared with the cation leak induced by
H734R single mutation (for H734R-expressing oocytes, the Li
influx is about 15 times higher than the control, whereas for
cysteine mutants in TM5, it is between 2 and 4 times higher
than the control). Differences in the expression levels of the
proteins in oocyte plasma membrane do not account for this
observation. This should rather mean that the cation pathway
induced by H734R mutation is more permeable than that
induced by cysteine substitutions in TM5. The fact that differ-
ent point mutations lead to varying intensities of the ouabain-
and bumetanide-insensitive cation leak but similar plasma
membrane protein content favors the hypothesis of a leak
through AE1 rather than through an endogenous transporter.
Moreover, some cysteine substitutions in TM5 were able to
increase the cation leak of H734R mutant, corroborating the
involvement of TM5 in cation permeability.
The question of a unique transport pathway in AE1 account-
ing for anion exchange and/or cation leak has been addressed in
a previous publication (11). It was observed that thiol reagent
binding on cysteine residues in TM8 could block anion
exchange on WT AE1 or cation leak in H734R point-mutated
AE1.The present resultswith L530Cand I533C substitutions in
H734RAE1 show that the cation leak could be partly blocked by
PCMBS binding on Cys530 or Cys533. Consequently, like TM8,
TM5 participates in the anion exchange activity of WT human
AE1 and in the cation leak activity of point-mutated H734R
AE1. However, cation leak inhibition is lower than anion trans-
port inhibition (Figs. 5B and 4A). This suggests that in H734R-
mutated AE1 a path still large enough with PCMBS binding on
Cys530 or Cys533 accounts for some Li transport.
The similarity between uracil transporter UraA and the AE1
model suggests that the two proteins should share a common
transportmechanism.The uracil transporterUraA is organized
into a core domain (TM1–4 and TM8–11) and a gate domain
(TM5–7 and TM12–14). The interface between these two
domains involves hydrophobic contacts of TM5 and TM12 in
the gate domain with TM3–8 and TM10 in the core domain.
The substrate binding site is located in a pocket formed at the
junction of TM3 and TM10 -helical parts. In this pocket, ura-
cil is coordinated with residues in TM8 (Glu241 and His245),
TM3 (Phe73), TM10 (Gly289 and Glu290), and TM12 (Tyr342)
(27). UraA is a proton-coupled symporter. It is proposed that
substrate-free UraA is outward-open with the two negative
charges of Glu (241 and 290) preventing closure of the gate
Structural Model of SLC4A1 and Transport Site Identification
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domain onto the core domain. The proton is translocated from
Glu241 orGlu290 toHis245, and this translocation induces a rota-
tion of the gate domain around the bound uracil. Then trans-
porter conformation changes from outward-open to inward-
open. Along TM8, substitution of Glu241 or His245 by an Ala
abolished uracil transport.
It is noteworthy that, in AE1, TM8 also lines the AE1 trans-
port site (19), and along this helix, Glu681 is involved in the
electroneutral anion exchange activity of the protein (18).
There is 62% similarity between UraA TM8 and AE1 TM8 pri-
mary sequences, and the size of the helices is the same. The two
Glu residues important for protein function are not at the same
level along the helix: Glu681 in AE1 is one helix turn lower than
Glu241 in UraA TM8 (supplemental Fig. 6). Glu681 in AE1 was
proposed to lie within the transport pathway and to be alterna-
tively exposed to the intracellular and extracellular media (18,
47, 48). Interestingly, Glu681 in the presentmodel is in the vicin-
ity of residues His734, Ser731 (in TM10), and Asp705 (in TM9).
Point mutations leading to H734R, S731P, and D705Y substi-
tutions (responsible for hereditary stomatocytosis) block anion
exchange and induce a cation conductance in AE1 (5, 9). The
work fromZaki et al. (47) has shown that two arginyl residues in
AE1 membrane-spanning domain are involved in the anion
binding site. These arginines were identified as Arg490
(extremely conserved residue in SLC4) and Arg730 (conserved
in SLC4A1, -A2, and -A3). In our model, the side chain of
Arg490 in TM4 protrudes toward the helical part of TM3,
whereas Arg730, located at the beginning of the TM10 helical
part, faces Glu681 in TM8 (Fig. 1C). Arg730 in AE1 TM10 cor-
responds to Glu290 in UraA TM10. These residues in their
respective transporter are deeply involved in the transport
activity of the proteins. E290A substitution in UraA abolishes
uracil transport, whereas R730C substitution abolishes anion
exchange activity of AE1 (49).
In addition to TM8, TM3 might also be involved in the AE1
transport pathway as it is in uracil transporter. Phe471 was
shown to be accessible to thiol reagent blocking when substi-
tuted with a cysteine. In UraA, a Phe (Phe73) is also found in a
similar position along TM3 (supplemental Fig. 6). This Phe73
can be substituted with an Ala without impairing uracil trans-
port; however, this bulky residue togetherwithHis245 in TM8 is
proposed to insulate substrate from the outside environment.
Finally, TM5 appears to face the AE1 transport pathway and to
control the size or the shape of this passage. Positions Phe528,
Leu530, and Ile533 in AE1 correspond to Ile132, Leu136, and
Val139, respectively, in UraA. In UraA, these residues mediate
interaction of the gate domain with the core domain. In the
upper part of AE1 TM5, Tyr534, Phe537, Lys539, and Lys542 face
Leu468, Glu472, Glu473, and Phe475 in TM3. Substitutions on
most of these residues were shown to affect anion exchange
activity. This suggests that these contacts are required for
proper functioning of AE1.
According to UraA transporter functioning and similarities
betweenUraA andAE1 regarding amino acids crucial for trans-
port, it could be proposed that the extracellular side of TM1,
TM2, TM3, TM8, and TM9 should circumscribe the AE1 out-
side vestibule, providing access for the extracellular medium.
The intracellular part of TM5, TM8, TM10, andTM12with the
loop connecting TM12 and TM13 should circumscribe the
inside vestibule, providing access for the intracellular medium.
A core domain consisting of TM1, TM2, TM3, TM4, TM8,
TM9, TM10, and TM11 would interact with a gate domain
(TM5, TM6, TM7, TM12, TM13, and TM14) (Fig. 1D). A tilt of
the gate domain should open and close the extracellular
medium access to the transport binding site formed around the
helical extremities of TM3 and TM10.
AE1 structure should enable anion exchange by a movement
of the protein that is compatible with the opening of a leak for
Na and K. The present three-dimensional model provides a
useful basis to design further experiments to understand how a
unique ion pathway within AE1 protein could exchange anions
and/or leak cations. The model could help identification of
helices in AE1 crystals, and it is a starting point to model point
mutations and to study their involvement in the organization
and functioning of the transport domain in silico and in vivo.
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